About the Speaker:- Dr Gautam Das is the Co-Founder & Chief Executive Officer of a genomics company 'miBiome Therapeutics LLP' (https://mibiome.com/), specializing in healthcare, pharmaceuticals, agriculture and biotechnology, he is the Chief Scientific Advisor of Microbiome Research Pvt. Ltd. (http://www.microbiome.in).

He did his Masters in Animal Sciences from University of Hyderabad, PhD in Molecular Microbiology from the Indian Institute of Science, Bengaluru and post-doctoral research in genomics and cancer at the University of Massachusetts Medical School, USA.

He has over 17 years of post-Ph.D. experience in research with 19 peer-reviewed high-impact international publications (7 of them from miBiome), with >1500 citations and 15 granted patents from USA, India, Israel and Australia.

He worked at the R & D division of Reliance Industries Limited (RIL) as Asst. Vice-President and Head of Biomaterials (Synthetic Biology).

He serves as a member of the Advisory and Monitoring Board of Government-appointed committee and has served as Scientific Consultant for a reputed NGO and as a member at RIL’s Joint Technical Committee and Institutional Bio-Safety Committee.

He has served as Associate Faculty Member of ‘Faculty of 1000’.

He has won several awards, including the ‘Special Recognition Award for Genetic Modification Efforts’, ‘Team Excellence Award’, ‘Leadership Excellence Award’ and ‘Synthetic Biology Catalyst Award’, at RIL.

He has presented several posters and talks and is an invited speaker in several forums in the government as well as private sector.

He is a Member of Genetics Society of America, USA, Society of Biological Chemists, India and is active in community service, cultural societies and philanthropy. He participates in Board of Studies committees of universities and is an industry expert of the ‘Omics’ course of IIT-Jodhpur.

Social Media accounts

1. LinkedIn: https://www.linkedin.com/in/dr-gautam-das-ph-d-005441b/
2. Twitter: https://twitter.com/gautambio
3. Facebook: https://www.facebook.com/gautam.das.9231/
Instagram: https://www.instagram.com/dr_gautam_das/

Abstract:- Humans have evolved with their own genomes (first genome) and a much larger number of microbial genomes, collectively known as the microbiome or the second genome. To understand the significance and implications of the host and the microbial genomes, it is essential to know the sequences of these genomes first. Genomics has the power to unlock the secrets of the host and microbial genomes. Using the technologies of DNA reading (through Next-Generation Sequencing or NGS), a genomics start-up in Mumbai, miBiome Therapeutics is at the forefront of understanding the role of human and microbial genomes in health and disease.

First Genome: Results on clinical genomics and precision medicine workflows for diseases such as cancer and inherited rare genetic diseases will be presented. Applications of NGS in transplant genomics will also be presented.
Second Genome: The associations between nutrigenomics and the gut microbiome and our studies on vaginal, skin, oral microbiome will be presented.

Third Genome: miBiome’s development of a ‘Cost-effective’, ‘Make-in –India’ Targeted NGS (T-NGS) solution for Tuberculosis (TB) Drug resistance which is cheaper, faster and better, will be presented.

Interdisciplinary approaches using genomics and integrating Artificial Intelligence (AI) and Machine Learning (ML) in computational analysis of genome and other health data will be presented.